Invention Grant
- Patent Title: Dalcetrapib for therapeutic use
-
Application No.: US14863148Application Date: 2015-09-23
-
Publication No.: US09909178B2Publication Date: 2018-03-06
- Inventor: Marie-Pierre Dube , Eric J. Niesor , Jean-Claude Tardif , Ruchi Upmanyu
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Grant Kalinowski
- Priority: EP13161386 20130327
- Main IPC: A61K31/16
- IPC: A61K31/16 ; A61K31/165 ; A01N37/18 ; C12Q1/68 ; A61K31/167
Abstract:
The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator.
Public/Granted literature
- US20160244826A1 GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY Public/Granted day:2016-08-25
Information query
